PER
Click for more information
0.00% 8.0¢ percheron therapeutics limited

Ann: First Patient Dosed in ATL1102 Phase IIb DMD Trial, page-18

  1. Quay Street
    472 Posts.
    lightbulb Created with Sketch. 58
    clock Created with Sketch.
    08/06/23
    14:07
    Post #: 68197006
    Im a bit confused about ATL1102 and needs for Animal Dosing and Toxicology trials.
    ATL1102 was used years ago for the MS study, where it was proved to be effective, but apparently not a commercial goer.
    It may be because of the age of the current test subjects but the safety and toxicology should be the same.
    Anyone know?
    QS
    ANP Price at posting: 6.8¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

LU7 Filling the Lithium Conversion Gap: Lithium Universe commits to community collaboration through formation of joint committee for Bécancour
right-arrow Created with Sketch.
WR1 Stock watchers charged up by Winsome Resources' latest lithium drilling results
right-arrow Created with Sketch.
SBW Shekel Brainweigh provides key business update ahead of final 2024 quarter
right-arrow Created with Sketch.
NEWS Good habits matters when it comes to finances
right-arrow Created with Sketch.
NEWS Earnings wrap Monday Week 34: A2 Milk, Bluescope, Suncorp's climate woes & more
right-arrow Created with Sketch.
NEWS Want to talk crypto? Click here to join the discussion!
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $72.12M
Open High Low Value Volume
7.9¢ 8.0¢ 7.9¢ $33.85K 424.8K

Buyers (Bids)

No. Vol. Price($)
3 76080 7.8¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 10226 1
View Market Depth
Last trade - 16.10pm 23/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.